drugset / Trial / NCT07463404
Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement
Timeline
- Start
- 2023-12-01
- Primary completion
- 2025-06-01
- Completion
- 2025-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meloxicam | Small molecule | 15 mg | — |
| Subject | Platelet Rich Plasma | Other / unclassified | — | Other |